nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—Gemcitabine—pancreatic cancer	0.424	1	CrCtD
Lamivudine—Zalcitabine—Gemcitabine—pancreatic cancer	0.116	0.522	CrCrCtD
Lamivudine—CMPK1—Gemcitabine—pancreatic cancer	0.097	0.386	CbGbCtD
Lamivudine—Cytarabine—Gemcitabine—pancreatic cancer	0.0557	0.251	CrCrCtD
Lamivudine—Decitabine—Gemcitabine—pancreatic cancer	0.0504	0.227	CrCrCtD
Lamivudine—DCK—Gemcitabine—pancreatic cancer	0.0248	0.0986	CbGbCtD
Lamivudine—ABCC3—Fluorouracil—pancreatic cancer	0.011	0.0437	CbGbCtD
Lamivudine—SLC22A3—Irinotecan—pancreatic cancer	0.0108	0.0429	CbGbCtD
Lamivudine—ABCC4—Fluorouracil—pancreatic cancer	0.0084	0.0334	CbGbCtD
Lamivudine—ABCC1—Epirubicin—pancreatic cancer	0.00723	0.0288	CbGbCtD
Lamivudine—ABCC1—Irinotecan—pancreatic cancer	0.00704	0.028	CbGbCtD
Lamivudine—ABCC2—Tamoxifen—pancreatic cancer	0.00678	0.027	CbGbCtD
Lamivudine—ABCC4—Sunitinib—pancreatic cancer	0.00639	0.0254	CbGbCtD
Lamivudine—ABCC3—Doxorubicin—pancreatic cancer	0.00626	0.0249	CbGbCtD
Lamivudine—ABCG2—Tamoxifen—pancreatic cancer	0.00613	0.0244	CbGbCtD
Lamivudine—ABCG2—Erlotinib—pancreatic cancer	0.00521	0.0207	CbGbCtD
Lamivudine—ABCC2—Irinotecan—pancreatic cancer	0.00521	0.0207	CbGbCtD
Lamivudine—ABCC1—Docetaxel—pancreatic cancer	0.00516	0.0205	CbGbCtD
Lamivudine—ABCG2—Irinotecan—pancreatic cancer	0.00471	0.0187	CbGbCtD
Lamivudine—ABCG2—Fluorouracil—pancreatic cancer	0.00452	0.018	CbGbCtD
Lamivudine—ABCC1—Doxorubicin—pancreatic cancer	0.00384	0.0153	CbGbCtD
Lamivudine—ABCC2—Docetaxel—pancreatic cancer	0.00382	0.0152	CbGbCtD
Lamivudine—ABCC2—Sunitinib—pancreatic cancer	0.0038	0.0151	CbGbCtD
Lamivudine—ABCG2—Docetaxel—pancreatic cancer	0.00345	0.0137	CbGbCtD
Lamivudine—ABCG2—Sunitinib—pancreatic cancer	0.00344	0.0137	CbGbCtD
Lamivudine—ABCC2—Doxorubicin—pancreatic cancer	0.00285	0.0113	CbGbCtD
Lamivudine—ABCC3—bile duct—pancreatic cancer	0.00274	0.167	CbGeAlD
Lamivudine—ABCG2—Doxorubicin—pancreatic cancer	0.00257	0.0102	CbGbCtD
Lamivudine—ABCB1—Tamoxifen—pancreatic cancer	0.00221	0.00879	CbGbCtD
Lamivudine—ABCC2—bile duct—pancreatic cancer	0.00219	0.133	CbGeAlD
Lamivudine—ABCB1—Gemcitabine—pancreatic cancer	0.0019	0.00758	CbGbCtD
Lamivudine—ABCB1—Erlotinib—pancreatic cancer	0.00188	0.00748	CbGbCtD
Lamivudine—ABCB1—Irinotecan—pancreatic cancer	0.0017	0.00675	CbGbCtD
Lamivudine—ABCC2—bile—pancreatic cancer	0.00168	0.102	CbGeAlD
Lamivudine—ABCB1—Docetaxel—pancreatic cancer	0.00124	0.00495	CbGbCtD
Lamivudine—ABCB1—Sunitinib—pancreatic cancer	0.00124	0.00493	CbGbCtD
Lamivudine—PCYT2—digestive system—pancreatic cancer	0.0011	0.0669	CbGeAlD
Lamivudine—PGK1—digestive system—pancreatic cancer	0.000945	0.0575	CbGeAlD
Lamivudine—ABCB1—Doxorubicin—pancreatic cancer	0.000928	0.00369	CbGbCtD
Lamivudine—CMPK1—islet of Langerhans—pancreatic cancer	0.000804	0.0489	CbGeAlD
Lamivudine—NME2—islet of Langerhans—pancreatic cancer	0.000786	0.0478	CbGeAlD
Lamivudine—PCYT1A—digestive system—pancreatic cancer	0.000749	0.0455	CbGeAlD
Lamivudine—Zalcitabine—SLC29A1—pancreatic cancer	0.000677	0.333	CrCbGaD
Lamivudine—Gemcitabine—SLC29A1—pancreatic cancer	0.000666	0.327	CrCbGaD
Lamivudine—ABCC3—gall bladder—pancreatic cancer	0.000585	0.0355	CbGeAlD
Lamivudine—CMPK1—pancreas—pancreatic cancer	0.000565	0.0344	CbGeAlD
Lamivudine—NME2—pancreas—pancreatic cancer	0.000552	0.0336	CbGeAlD
Lamivudine—NME1—digestive system—pancreatic cancer	0.000501	0.0304	CbGeAlD
Lamivudine—CMPK1—digestive system—pancreatic cancer	0.000483	0.0293	CbGeAlD
Lamivudine—NME2—digestive system—pancreatic cancer	0.000472	0.0287	CbGeAlD
Lamivudine—Cytarabine—SLC29A1—pancreatic cancer	0.000455	0.223	CrCbGaD
Lamivudine—DCK—islet of Langerhans—pancreatic cancer	0.0004	0.0243	CbGeAlD
Lamivudine—DCK—Topotecan—Irinotecan—pancreatic cancer	0.000363	0.315	CbGdCrCtD
Lamivudine—NME1—Gefitinib—Erlotinib—pancreatic cancer	0.000359	0.312	CbGdCrCtD
Lamivudine—SLC22A2—digestive system—pancreatic cancer	0.00029	0.0176	CbGeAlD
Lamivudine—DCK—pancreas—pancreatic cancer	0.000281	0.0171	CbGeAlD
Lamivudine—DCK—digestive system—pancreatic cancer	0.00024	0.0146	CbGeAlD
Lamivudine—Gemcitabine—TYMS—pancreatic cancer	0.000237	0.117	CrCbGaD
Lamivudine—ABCC3—digestive system—pancreatic cancer	0.00023	0.014	CbGeAlD
Lamivudine—ABCC4—pancreas—pancreatic cancer	0.000222	0.0135	CbGeAlD
Lamivudine—ABCC4—digestive system—pancreatic cancer	0.00019	0.0115	CbGeAlD
Lamivudine—ABCC2—digestive system—pancreatic cancer	0.000184	0.0112	CbGeAlD
Lamivudine—NME1—Loperamide—Tamoxifen—pancreatic cancer	0.000154	0.134	CbGdCrCtD
Lamivudine—DCK—Clomifene—Tamoxifen—pancreatic cancer	0.000112	0.097	CbGdCrCtD
Lamivudine—ABCB1—islet of Langerhans—pancreatic cancer	0.00011	0.00669	CbGeAlD
Lamivudine—DCK—Doxorubicin—Epirubicin—pancreatic cancer	8.53e-05	0.0741	CbGdCrCtD
Lamivudine—DCK—Epirubicin—Doxorubicin—pancreatic cancer	7.9e-05	0.0685	CbGdCrCtD
Lamivudine—ABCB1—pancreas—pancreatic cancer	7.74e-05	0.00471	CbGeAlD
Lamivudine—ABCB1—digestive system—pancreatic cancer	6.61e-05	0.00402	CbGeAlD
Lamivudine—Dermatitis—Sunitinib—pancreatic cancer	3.44e-05	0.000701	CcSEcCtD
Lamivudine—Abdominal distension—Doxorubicin—pancreatic cancer	3.44e-05	0.000701	CcSEcCtD
Lamivudine—Urticaria—Fluorouracil—pancreatic cancer	3.43e-05	0.000698	CcSEcCtD
Lamivudine—Headache—Sunitinib—pancreatic cancer	3.42e-05	0.000698	CcSEcCtD
Lamivudine—Syncope—Docetaxel—pancreatic cancer	3.42e-05	0.000697	CcSEcCtD
Lamivudine—Dysphagia—Doxorubicin—pancreatic cancer	3.42e-05	0.000696	CcSEcCtD
Lamivudine—Influenza—Doxorubicin—pancreatic cancer	3.42e-05	0.000696	CcSEcCtD
Lamivudine—Leukopenia—Docetaxel—pancreatic cancer	3.41e-05	0.000695	CcSEcCtD
Lamivudine—Pollakiuria—Epirubicin—pancreatic cancer	3.41e-05	0.000695	CcSEcCtD
Lamivudine—Body temperature increased—Fluorouracil—pancreatic cancer	3.41e-05	0.000694	CcSEcCtD
Lamivudine—Loss of consciousness—Docetaxel—pancreatic cancer	3.35e-05	0.000683	CcSEcCtD
Lamivudine—Pancreatitis—Doxorubicin—pancreatic cancer	3.35e-05	0.000682	CcSEcCtD
Lamivudine—Hyperglycaemia—Epirubicin—pancreatic cancer	3.33e-05	0.000678	CcSEcCtD
Lamivudine—Cough—Docetaxel—pancreatic cancer	3.33e-05	0.000678	CcSEcCtD
Lamivudine—Hypersensitivity—Irinotecan—pancreatic cancer	3.32e-05	0.000676	CcSEcCtD
Lamivudine—Convulsion—Docetaxel—pancreatic cancer	3.3e-05	0.000673	CcSEcCtD
Lamivudine—Bronchitis—Doxorubicin—pancreatic cancer	3.29e-05	0.000669	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	3.26e-05	0.000665	CcSEcCtD
Lamivudine—Myalgia—Docetaxel—pancreatic cancer	3.25e-05	0.000661	CcSEcCtD
Lamivudine—Arthralgia—Docetaxel—pancreatic cancer	3.25e-05	0.000661	CcSEcCtD
Lamivudine—Chest pain—Docetaxel—pancreatic cancer	3.25e-05	0.000661	CcSEcCtD
Lamivudine—Nausea—Sunitinib—pancreatic cancer	3.25e-05	0.000661	CcSEcCtD
Lamivudine—Pancytopenia—Doxorubicin—pancreatic cancer	3.24e-05	0.000661	CcSEcCtD
Lamivudine—Renal failure—Epirubicin—pancreatic cancer	3.24e-05	0.000659	CcSEcCtD
Lamivudine—Asthenia—Irinotecan—pancreatic cancer	3.23e-05	0.000658	CcSEcCtD
Lamivudine—Neuropathy peripheral—Epirubicin—pancreatic cancer	3.23e-05	0.000657	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	3.22e-05	0.000657	CcSEcCtD
Lamivudine—Stomatitis—Epirubicin—pancreatic cancer	3.21e-05	0.000654	CcSEcCtD
Lamivudine—Jaundice—Epirubicin—pancreatic cancer	3.21e-05	0.000654	CcSEcCtD
Lamivudine—Dysuria—Doxorubicin—pancreatic cancer	3.19e-05	0.000651	CcSEcCtD
Lamivudine—Neutropenia—Doxorubicin—pancreatic cancer	3.19e-05	0.000651	CcSEcCtD
Lamivudine—Hypersensitivity—Fluorouracil—pancreatic cancer	3.18e-05	0.000647	CcSEcCtD
Lamivudine—Dry mouth—Docetaxel—pancreatic cancer	3.18e-05	0.000647	CcSEcCtD
Lamivudine—Sweating—Epirubicin—pancreatic cancer	3.16e-05	0.000643	CcSEcCtD
Lamivudine—Pollakiuria—Doxorubicin—pancreatic cancer	3.16e-05	0.000643	CcSEcCtD
Lamivudine—Asthenia—Gemcitabine—pancreatic cancer	3.15e-05	0.000641	CcSEcCtD
Lamivudine—Confusional state—Docetaxel—pancreatic cancer	3.14e-05	0.000639	CcSEcCtD
Lamivudine—Hepatobiliary disease—Epirubicin—pancreatic cancer	3.11e-05	0.000634	CcSEcCtD
Lamivudine—Oedema—Docetaxel—pancreatic cancer	3.11e-05	0.000634	CcSEcCtD
Lamivudine—Anaphylactic shock—Docetaxel—pancreatic cancer	3.11e-05	0.000634	CcSEcCtD
Lamivudine—Epistaxis—Epirubicin—pancreatic cancer	3.11e-05	0.000632	CcSEcCtD
Lamivudine—Pruritus—Gemcitabine—pancreatic cancer	3.1e-05	0.000632	CcSEcCtD
Lamivudine—Infection—Docetaxel—pancreatic cancer	3.09e-05	0.00063	CcSEcCtD
Lamivudine—Sinusitis—Epirubicin—pancreatic cancer	3.09e-05	0.000629	CcSEcCtD
Lamivudine—Hyperglycaemia—Doxorubicin—pancreatic cancer	3.08e-05	0.000628	CcSEcCtD
Lamivudine—Diarrhoea—Irinotecan—pancreatic cancer	3.08e-05	0.000628	CcSEcCtD
Lamivudine—Agranulocytosis—Epirubicin—pancreatic cancer	3.07e-05	0.000626	CcSEcCtD
Lamivudine—Shock—Docetaxel—pancreatic cancer	3.06e-05	0.000624	CcSEcCtD
Lamivudine—Nervous system disorder—Docetaxel—pancreatic cancer	3.05e-05	0.000622	CcSEcCtD
Lamivudine—Pruritus—Fluorouracil—pancreatic cancer	3.05e-05	0.000621	CcSEcCtD
Lamivudine—Thrombocytopenia—Docetaxel—pancreatic cancer	3.05e-05	0.000621	CcSEcCtD
Lamivudine—Skin disorder—Docetaxel—pancreatic cancer	3.02e-05	0.000616	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	3.02e-05	0.000615	CcSEcCtD
Lamivudine—Diarrhoea—Gemcitabine—pancreatic cancer	3e-05	0.000611	CcSEcCtD
Lamivudine—Renal failure—Doxorubicin—pancreatic cancer	2.99e-05	0.00061	CcSEcCtD
Lamivudine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	2.99e-05	0.000608	CcSEcCtD
Lamivudine—Dizziness—Irinotecan—pancreatic cancer	2.98e-05	0.000607	CcSEcCtD
Lamivudine—Stomatitis—Doxorubicin—pancreatic cancer	2.97e-05	0.000605	CcSEcCtD
Lamivudine—Jaundice—Doxorubicin—pancreatic cancer	2.97e-05	0.000605	CcSEcCtD
Lamivudine—Anorexia—Docetaxel—pancreatic cancer	2.97e-05	0.000604	CcSEcCtD
Lamivudine—Rhinitis—Epirubicin—pancreatic cancer	2.96e-05	0.000603	CcSEcCtD
Lamivudine—Hepatitis—Epirubicin—pancreatic cancer	2.96e-05	0.000602	CcSEcCtD
Lamivudine—Diarrhoea—Fluorouracil—pancreatic cancer	2.95e-05	0.000601	CcSEcCtD
Lamivudine—Hypoaesthesia—Epirubicin—pancreatic cancer	2.94e-05	0.000599	CcSEcCtD
Lamivudine—Pharyngitis—Epirubicin—pancreatic cancer	2.93e-05	0.000597	CcSEcCtD
Lamivudine—Sweating—Doxorubicin—pancreatic cancer	2.92e-05	0.000595	CcSEcCtD
Lamivudine—Hypotension—Docetaxel—pancreatic cancer	2.91e-05	0.000592	CcSEcCtD
Lamivudine—Connective tissue disorder—Epirubicin—pancreatic cancer	2.9e-05	0.000592	CcSEcCtD
Lamivudine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	2.88e-05	0.000587	CcSEcCtD
Lamivudine—Epistaxis—Doxorubicin—pancreatic cancer	2.87e-05	0.000585	CcSEcCtD
Lamivudine—Vomiting—Irinotecan—pancreatic cancer	2.86e-05	0.000583	CcSEcCtD
Lamivudine—Sinusitis—Doxorubicin—pancreatic cancer	2.86e-05	0.000582	CcSEcCtD
Lamivudine—Dizziness—Fluorouracil—pancreatic cancer	2.85e-05	0.000581	CcSEcCtD
Lamivudine—Agranulocytosis—Doxorubicin—pancreatic cancer	2.84e-05	0.000579	CcSEcCtD
Lamivudine—Rash—Irinotecan—pancreatic cancer	2.84e-05	0.000578	CcSEcCtD
Lamivudine—Dermatitis—Irinotecan—pancreatic cancer	2.84e-05	0.000578	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	2.84e-05	0.000578	CcSEcCtD
Lamivudine—Headache—Irinotecan—pancreatic cancer	2.82e-05	0.000575	CcSEcCtD
Lamivudine—Insomnia—Docetaxel—pancreatic cancer	2.82e-05	0.000573	CcSEcCtD
Lamivudine—Paraesthesia—Docetaxel—pancreatic cancer	2.8e-05	0.000569	CcSEcCtD
Lamivudine—Erythema multiforme—Epirubicin—pancreatic cancer	2.79e-05	0.000569	CcSEcCtD
Lamivudine—Vomiting—Gemcitabine—pancreatic cancer	2.79e-05	0.000568	CcSEcCtD
Lamivudine—Dyspnoea—Docetaxel—pancreatic cancer	2.78e-05	0.000565	CcSEcCtD
Lamivudine—Somnolence—Docetaxel—pancreatic cancer	2.77e-05	0.000564	CcSEcCtD
Lamivudine—Rash—Gemcitabine—pancreatic cancer	2.77e-05	0.000563	CcSEcCtD
Lamivudine—Dermatitis—Gemcitabine—pancreatic cancer	2.76e-05	0.000563	CcSEcCtD
Lamivudine—Headache—Gemcitabine—pancreatic cancer	2.75e-05	0.00056	CcSEcCtD
Lamivudine—Vomiting—Fluorouracil—pancreatic cancer	2.74e-05	0.000559	CcSEcCtD
Lamivudine—Rhinitis—Doxorubicin—pancreatic cancer	2.74e-05	0.000558	CcSEcCtD
Lamivudine—Dyspepsia—Docetaxel—pancreatic cancer	2.74e-05	0.000558	CcSEcCtD
Lamivudine—Hepatitis—Doxorubicin—pancreatic cancer	2.73e-05	0.000557	CcSEcCtD
Lamivudine—Hypoaesthesia—Doxorubicin—pancreatic cancer	2.72e-05	0.000554	CcSEcCtD
Lamivudine—Rash—Fluorouracil—pancreatic cancer	2.72e-05	0.000554	CcSEcCtD
Lamivudine—Dermatitis—Fluorouracil—pancreatic cancer	2.72e-05	0.000553	CcSEcCtD
Lamivudine—Pharyngitis—Doxorubicin—pancreatic cancer	2.71e-05	0.000553	CcSEcCtD
Lamivudine—Decreased appetite—Docetaxel—pancreatic cancer	2.71e-05	0.000551	CcSEcCtD
Lamivudine—Headache—Fluorouracil—pancreatic cancer	2.7e-05	0.00055	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	2.69e-05	0.000547	CcSEcCtD
Lamivudine—Connective tissue disorder—Doxorubicin—pancreatic cancer	2.69e-05	0.000547	CcSEcCtD
Lamivudine—Fatigue—Docetaxel—pancreatic cancer	2.68e-05	0.000547	CcSEcCtD
Lamivudine—Nausea—Irinotecan—pancreatic cancer	2.67e-05	0.000545	CcSEcCtD
Lamivudine—Immune system disorder—Epirubicin—pancreatic cancer	2.67e-05	0.000544	CcSEcCtD
Lamivudine—Mediastinal disorder—Epirubicin—pancreatic cancer	2.66e-05	0.000542	CcSEcCtD
Lamivudine—Constipation—Docetaxel—pancreatic cancer	2.66e-05	0.000542	CcSEcCtD
Lamivudine—Pain—Docetaxel—pancreatic cancer	2.66e-05	0.000542	CcSEcCtD
Lamivudine—Chills—Epirubicin—pancreatic cancer	2.65e-05	0.00054	CcSEcCtD
Lamivudine—Alopecia—Epirubicin—pancreatic cancer	2.61e-05	0.000532	CcSEcCtD
Lamivudine—Nausea—Gemcitabine—pancreatic cancer	2.61e-05	0.000531	CcSEcCtD
Lamivudine—Erythema multiforme—Doxorubicin—pancreatic cancer	2.59e-05	0.000527	CcSEcCtD
Lamivudine—Erythema—Epirubicin—pancreatic cancer	2.57e-05	0.000524	CcSEcCtD
Lamivudine—Malnutrition—Epirubicin—pancreatic cancer	2.57e-05	0.000524	CcSEcCtD
Lamivudine—Feeling abnormal—Docetaxel—pancreatic cancer	2.57e-05	0.000522	CcSEcCtD
Lamivudine—Nausea—Fluorouracil—pancreatic cancer	2.56e-05	0.000522	CcSEcCtD
Lamivudine—Gastrointestinal pain—Docetaxel—pancreatic cancer	2.55e-05	0.000518	CcSEcCtD
Lamivudine—Flatulence—Epirubicin—pancreatic cancer	2.54e-05	0.000516	CcSEcCtD
Lamivudine—Tension—Epirubicin—pancreatic cancer	2.52e-05	0.000514	CcSEcCtD
Lamivudine—Dysgeusia—Epirubicin—pancreatic cancer	2.52e-05	0.000513	CcSEcCtD
Lamivudine—Nervousness—Epirubicin—pancreatic cancer	2.5e-05	0.000509	CcSEcCtD
Lamivudine—Back pain—Epirubicin—pancreatic cancer	2.49e-05	0.000507	CcSEcCtD
Lamivudine—Muscle spasms—Epirubicin—pancreatic cancer	2.47e-05	0.000504	CcSEcCtD
Lamivudine—Immune system disorder—Doxorubicin—pancreatic cancer	2.47e-05	0.000503	CcSEcCtD
Lamivudine—Mediastinal disorder—Doxorubicin—pancreatic cancer	2.46e-05	0.000502	CcSEcCtD
Lamivudine—Body temperature increased—Docetaxel—pancreatic cancer	2.46e-05	0.000501	CcSEcCtD
Lamivudine—Abdominal pain—Docetaxel—pancreatic cancer	2.46e-05	0.000501	CcSEcCtD
Lamivudine—Chills—Doxorubicin—pancreatic cancer	2.45e-05	0.0005	CcSEcCtD
Lamivudine—Alopecia—Doxorubicin—pancreatic cancer	2.42e-05	0.000492	CcSEcCtD
Lamivudine—Ill-defined disorder—Epirubicin—pancreatic cancer	2.39e-05	0.000486	CcSEcCtD
Lamivudine—Erythema—Doxorubicin—pancreatic cancer	2.38e-05	0.000485	CcSEcCtD
Lamivudine—Malnutrition—Doxorubicin—pancreatic cancer	2.38e-05	0.000485	CcSEcCtD
Lamivudine—Anaemia—Epirubicin—pancreatic cancer	2.38e-05	0.000484	CcSEcCtD
Lamivudine—Flatulence—Doxorubicin—pancreatic cancer	2.35e-05	0.000478	CcSEcCtD
Lamivudine—Tension—Doxorubicin—pancreatic cancer	2.34e-05	0.000476	CcSEcCtD
Lamivudine—Dysgeusia—Doxorubicin—pancreatic cancer	2.33e-05	0.000475	CcSEcCtD
Lamivudine—Malaise—Epirubicin—pancreatic cancer	2.32e-05	0.000473	CcSEcCtD
Lamivudine—Nervousness—Doxorubicin—pancreatic cancer	2.31e-05	0.000471	CcSEcCtD
Lamivudine—Vertigo—Epirubicin—pancreatic cancer	2.31e-05	0.000471	CcSEcCtD
Lamivudine—Syncope—Epirubicin—pancreatic cancer	2.31e-05	0.00047	CcSEcCtD
Lamivudine—Leukopenia—Epirubicin—pancreatic cancer	2.3e-05	0.000469	CcSEcCtD
Lamivudine—Back pain—Doxorubicin—pancreatic cancer	2.3e-05	0.000469	CcSEcCtD
Lamivudine—Hypersensitivity—Docetaxel—pancreatic cancer	2.29e-05	0.000467	CcSEcCtD
Lamivudine—Muscle spasms—Doxorubicin—pancreatic cancer	2.29e-05	0.000466	CcSEcCtD
Lamivudine—Loss of consciousness—Epirubicin—pancreatic cancer	2.26e-05	0.000461	CcSEcCtD
Lamivudine—Cough—Epirubicin—pancreatic cancer	2.25e-05	0.000457	CcSEcCtD
Lamivudine—Asthenia—Docetaxel—pancreatic cancer	2.23e-05	0.000455	CcSEcCtD
Lamivudine—Convulsion—Epirubicin—pancreatic cancer	2.23e-05	0.000454	CcSEcCtD
Lamivudine—Ill-defined disorder—Doxorubicin—pancreatic cancer	2.21e-05	0.00045	CcSEcCtD
Lamivudine—Pruritus—Docetaxel—pancreatic cancer	2.2e-05	0.000449	CcSEcCtD
Lamivudine—Anaemia—Doxorubicin—pancreatic cancer	2.2e-05	0.000448	CcSEcCtD
Lamivudine—Arthralgia—Epirubicin—pancreatic cancer	2.19e-05	0.000446	CcSEcCtD
Lamivudine—Myalgia—Epirubicin—pancreatic cancer	2.19e-05	0.000446	CcSEcCtD
Lamivudine—Chest pain—Epirubicin—pancreatic cancer	2.19e-05	0.000446	CcSEcCtD
Lamivudine—Anxiety—Epirubicin—pancreatic cancer	2.18e-05	0.000445	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	2.18e-05	0.000443	CcSEcCtD
Lamivudine—Discomfort—Epirubicin—pancreatic cancer	2.16e-05	0.000441	CcSEcCtD
Lamivudine—Malaise—Doxorubicin—pancreatic cancer	2.15e-05	0.000437	CcSEcCtD
Lamivudine—Dry mouth—Epirubicin—pancreatic cancer	2.14e-05	0.000436	CcSEcCtD
Lamivudine—Vertigo—Doxorubicin—pancreatic cancer	2.14e-05	0.000436	CcSEcCtD
Lamivudine—Syncope—Doxorubicin—pancreatic cancer	2.13e-05	0.000435	CcSEcCtD
Lamivudine—Leukopenia—Doxorubicin—pancreatic cancer	2.13e-05	0.000434	CcSEcCtD
Lamivudine—Diarrhoea—Docetaxel—pancreatic cancer	2.13e-05	0.000434	CcSEcCtD
Lamivudine—Confusional state—Epirubicin—pancreatic cancer	2.12e-05	0.000431	CcSEcCtD
Lamivudine—Anaphylactic shock—Epirubicin—pancreatic cancer	2.1e-05	0.000428	CcSEcCtD
Lamivudine—Oedema—Epirubicin—pancreatic cancer	2.1e-05	0.000428	CcSEcCtD
Lamivudine—Loss of consciousness—Doxorubicin—pancreatic cancer	2.09e-05	0.000426	CcSEcCtD
Lamivudine—Infection—Epirubicin—pancreatic cancer	2.09e-05	0.000425	CcSEcCtD
Lamivudine—Cough—Doxorubicin—pancreatic cancer	2.08e-05	0.000423	CcSEcCtD
Lamivudine—Shock—Epirubicin—pancreatic cancer	2.07e-05	0.000421	CcSEcCtD
Lamivudine—Convulsion—Doxorubicin—pancreatic cancer	2.06e-05	0.00042	CcSEcCtD
Lamivudine—Nervous system disorder—Epirubicin—pancreatic cancer	2.06e-05	0.000419	CcSEcCtD
Lamivudine—Dizziness—Docetaxel—pancreatic cancer	2.06e-05	0.000419	CcSEcCtD
Lamivudine—Thrombocytopenia—Epirubicin—pancreatic cancer	2.06e-05	0.000419	CcSEcCtD
Lamivudine—Skin disorder—Epirubicin—pancreatic cancer	2.04e-05	0.000415	CcSEcCtD
Lamivudine—Hyperhidrosis—Epirubicin—pancreatic cancer	2.03e-05	0.000413	CcSEcCtD
Lamivudine—Myalgia—Doxorubicin—pancreatic cancer	2.03e-05	0.000413	CcSEcCtD
Lamivudine—Arthralgia—Doxorubicin—pancreatic cancer	2.03e-05	0.000413	CcSEcCtD
Lamivudine—Chest pain—Doxorubicin—pancreatic cancer	2.03e-05	0.000413	CcSEcCtD
Lamivudine—Anxiety—Doxorubicin—pancreatic cancer	2.02e-05	0.000411	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	2.01e-05	0.00041	CcSEcCtD
Lamivudine—Discomfort—Doxorubicin—pancreatic cancer	2e-05	0.000408	CcSEcCtD
Lamivudine—Anorexia—Epirubicin—pancreatic cancer	2e-05	0.000408	CcSEcCtD
Lamivudine—Dry mouth—Doxorubicin—pancreatic cancer	1.98e-05	0.000404	CcSEcCtD
Lamivudine—Vomiting—Docetaxel—pancreatic cancer	1.98e-05	0.000403	CcSEcCtD
Lamivudine—Rash—Docetaxel—pancreatic cancer	1.96e-05	0.0004	CcSEcCtD
Lamivudine—Hypotension—Epirubicin—pancreatic cancer	1.96e-05	0.0004	CcSEcCtD
Lamivudine—Dermatitis—Docetaxel—pancreatic cancer	1.96e-05	0.000399	CcSEcCtD
Lamivudine—Confusional state—Doxorubicin—pancreatic cancer	1.96e-05	0.000399	CcSEcCtD
Lamivudine—Headache—Docetaxel—pancreatic cancer	1.95e-05	0.000397	CcSEcCtD
Lamivudine—Anaphylactic shock—Doxorubicin—pancreatic cancer	1.94e-05	0.000396	CcSEcCtD
Lamivudine—Oedema—Doxorubicin—pancreatic cancer	1.94e-05	0.000396	CcSEcCtD
Lamivudine—Infection—Doxorubicin—pancreatic cancer	1.93e-05	0.000393	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	1.91e-05	0.00039	CcSEcCtD
Lamivudine—Shock—Doxorubicin—pancreatic cancer	1.91e-05	0.000389	CcSEcCtD
Lamivudine—Nervous system disorder—Doxorubicin—pancreatic cancer	1.91e-05	0.000388	CcSEcCtD
Lamivudine—Thrombocytopenia—Doxorubicin—pancreatic cancer	1.9e-05	0.000387	CcSEcCtD
Lamivudine—Insomnia—Epirubicin—pancreatic cancer	1.9e-05	0.000387	CcSEcCtD
Lamivudine—Skin disorder—Doxorubicin—pancreatic cancer	1.89e-05	0.000384	CcSEcCtD
Lamivudine—Paraesthesia—Epirubicin—pancreatic cancer	1.89e-05	0.000384	CcSEcCtD
Lamivudine—Hyperhidrosis—Doxorubicin—pancreatic cancer	1.88e-05	0.000383	CcSEcCtD
Lamivudine—Dyspnoea—Epirubicin—pancreatic cancer	1.87e-05	0.000381	CcSEcCtD
Lamivudine—Somnolence—Epirubicin—pancreatic cancer	1.87e-05	0.00038	CcSEcCtD
Lamivudine—Anorexia—Doxorubicin—pancreatic cancer	1.85e-05	0.000377	CcSEcCtD
Lamivudine—Nausea—Docetaxel—pancreatic cancer	1.85e-05	0.000377	CcSEcCtD
Lamivudine—Dyspepsia—Epirubicin—pancreatic cancer	1.85e-05	0.000376	CcSEcCtD
Lamivudine—Decreased appetite—Epirubicin—pancreatic cancer	1.83e-05	0.000372	CcSEcCtD
Lamivudine—Hypotension—Doxorubicin—pancreatic cancer	1.82e-05	0.00037	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	1.81e-05	0.000369	CcSEcCtD
Lamivudine—Fatigue—Epirubicin—pancreatic cancer	1.81e-05	0.000369	CcSEcCtD
Lamivudine—Pain—Epirubicin—pancreatic cancer	1.8e-05	0.000366	CcSEcCtD
Lamivudine—Constipation—Epirubicin—pancreatic cancer	1.8e-05	0.000366	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	1.77e-05	0.000361	CcSEcCtD
Lamivudine—Insomnia—Doxorubicin—pancreatic cancer	1.76e-05	0.000358	CcSEcCtD
Lamivudine—Paraesthesia—Doxorubicin—pancreatic cancer	1.74e-05	0.000355	CcSEcCtD
Lamivudine—Dyspnoea—Doxorubicin—pancreatic cancer	1.73e-05	0.000353	CcSEcCtD
Lamivudine—Feeling abnormal—Epirubicin—pancreatic cancer	1.73e-05	0.000352	CcSEcCtD
Lamivudine—Somnolence—Doxorubicin—pancreatic cancer	1.73e-05	0.000352	CcSEcCtD
Lamivudine—Gastrointestinal pain—Epirubicin—pancreatic cancer	1.72e-05	0.00035	CcSEcCtD
Lamivudine—Dyspepsia—Doxorubicin—pancreatic cancer	1.71e-05	0.000348	CcSEcCtD
Lamivudine—Decreased appetite—Doxorubicin—pancreatic cancer	1.69e-05	0.000344	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	1.68e-05	0.000342	CcSEcCtD
Lamivudine—Fatigue—Doxorubicin—pancreatic cancer	1.67e-05	0.000341	CcSEcCtD
Lamivudine—Urticaria—Epirubicin—pancreatic cancer	1.67e-05	0.00034	CcSEcCtD
Lamivudine—Pain—Doxorubicin—pancreatic cancer	1.66e-05	0.000338	CcSEcCtD
Lamivudine—Constipation—Doxorubicin—pancreatic cancer	1.66e-05	0.000338	CcSEcCtD
Lamivudine—Abdominal pain—Epirubicin—pancreatic cancer	1.66e-05	0.000338	CcSEcCtD
Lamivudine—Body temperature increased—Epirubicin—pancreatic cancer	1.66e-05	0.000338	CcSEcCtD
Lamivudine—Feeling abnormal—Doxorubicin—pancreatic cancer	1.6e-05	0.000326	CcSEcCtD
Lamivudine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	1.59e-05	0.000324	CcSEcCtD
Lamivudine—Hypersensitivity—Epirubicin—pancreatic cancer	1.55e-05	0.000315	CcSEcCtD
Lamivudine—Urticaria—Doxorubicin—pancreatic cancer	1.54e-05	0.000314	CcSEcCtD
Lamivudine—Abdominal pain—Doxorubicin—pancreatic cancer	1.54e-05	0.000313	CcSEcCtD
Lamivudine—Body temperature increased—Doxorubicin—pancreatic cancer	1.54e-05	0.000313	CcSEcCtD
Lamivudine—Asthenia—Epirubicin—pancreatic cancer	1.51e-05	0.000307	CcSEcCtD
Lamivudine—Pruritus—Epirubicin—pancreatic cancer	1.49e-05	0.000303	CcSEcCtD
Lamivudine—Diarrhoea—Epirubicin—pancreatic cancer	1.44e-05	0.000293	CcSEcCtD
Lamivudine—Hypersensitivity—Doxorubicin—pancreatic cancer	1.43e-05	0.000292	CcSEcCtD
Lamivudine—Asthenia—Doxorubicin—pancreatic cancer	1.39e-05	0.000284	CcSEcCtD
Lamivudine—Dizziness—Epirubicin—pancreatic cancer	1.39e-05	0.000283	CcSEcCtD
Lamivudine—Pruritus—Doxorubicin—pancreatic cancer	1.37e-05	0.00028	CcSEcCtD
Lamivudine—Vomiting—Epirubicin—pancreatic cancer	1.34e-05	0.000272	CcSEcCtD
Lamivudine—Diarrhoea—Doxorubicin—pancreatic cancer	1.33e-05	0.000271	CcSEcCtD
Lamivudine—Rash—Epirubicin—pancreatic cancer	1.32e-05	0.00027	CcSEcCtD
Lamivudine—Dermatitis—Epirubicin—pancreatic cancer	1.32e-05	0.000269	CcSEcCtD
Lamivudine—Headache—Epirubicin—pancreatic cancer	1.32e-05	0.000268	CcSEcCtD
Lamivudine—Dizziness—Doxorubicin—pancreatic cancer	1.28e-05	0.000262	CcSEcCtD
Lamivudine—Nausea—Epirubicin—pancreatic cancer	1.25e-05	0.000254	CcSEcCtD
Lamivudine—Vomiting—Doxorubicin—pancreatic cancer	1.24e-05	0.000252	CcSEcCtD
Lamivudine—Rash—Doxorubicin—pancreatic cancer	1.22e-05	0.000249	CcSEcCtD
Lamivudine—Dermatitis—Doxorubicin—pancreatic cancer	1.22e-05	0.000249	CcSEcCtD
Lamivudine—Headache—Doxorubicin—pancreatic cancer	1.22e-05	0.000248	CcSEcCtD
Lamivudine—Nausea—Doxorubicin—pancreatic cancer	1.15e-05	0.000235	CcSEcCtD
Lamivudine—SLC22A1—Metabolism—PRSS1—pancreatic cancer	7.82e-06	0.000233	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PTGS2—pancreatic cancer	7.77e-06	0.000232	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PIK3CG—pancreatic cancer	7.76e-06	0.000231	CbGpPWpGaD
Lamivudine—PGK1—Disease—EGFR—pancreatic cancer	7.74e-06	0.000231	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	7.69e-06	0.000229	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	7.63e-06	0.000227	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—SLC2A2—pancreatic cancer	7.63e-06	0.000227	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HEY1—pancreatic cancer	7.56e-06	0.000225	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GLP1R—pancreatic cancer	7.51e-06	0.000224	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	7.5e-06	0.000224	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PPARG—pancreatic cancer	7.49e-06	0.000223	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—PTEN—pancreatic cancer	7.41e-06	0.000221	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—DPYD—pancreatic cancer	7.39e-06	0.00022	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ARG2—pancreatic cancer	7.35e-06	0.000219	CbGpPWpGaD
Lamivudine—PGK1—Disease—KRAS—pancreatic cancer	7.31e-06	0.000218	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—TYMP—pancreatic cancer	7.3e-06	0.000217	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ARG2—pancreatic cancer	7.27e-06	0.000217	CbGpPWpGaD
Lamivudine—DCK—Metabolism—TYMS—pancreatic cancer	7.25e-06	0.000216	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—PIK3CG—pancreatic cancer	7.16e-06	0.000213	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—EGF—pancreatic cancer	7.08e-06	0.000211	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—SLC2A2—pancreatic cancer	7.01e-06	0.000209	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	6.94e-06	0.000207	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—PIK3CA—pancreatic cancer	6.9e-06	0.000206	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—PIK3CA—pancreatic cancer	6.9e-06	0.000206	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—PIK3CA—pancreatic cancer	6.9e-06	0.000206	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	6.89e-06	0.000205	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PIK3CD—pancreatic cancer	6.82e-06	0.000203	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PTEN—pancreatic cancer	6.78e-06	0.000202	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ARG2—pancreatic cancer	6.78e-06	0.000202	CbGpPWpGaD
Lamivudine—PGK1—Disease—PIK3CA—pancreatic cancer	6.72e-06	0.0002	CbGpPWpGaD
Lamivudine—ABCC1—Disease—JAG2—pancreatic cancer	6.7e-06	0.0002	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	6.7e-06	0.000199	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MEN1—pancreatic cancer	6.61e-06	0.000197	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SLC2A2—pancreatic cancer	6.56e-06	0.000195	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	6.49e-06	0.000193	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—TNF—pancreatic cancer	6.43e-06	0.000192	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—TYMP—pancreatic cancer	6.42e-06	0.000191	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	6.39e-06	0.000191	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—TYMP—pancreatic cancer	6.36e-06	0.000189	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SHH—pancreatic cancer	6.3e-06	0.000188	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—PIK3CD—pancreatic cancer	6.3e-06	0.000188	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IAPP—pancreatic cancer	6.22e-06	0.000185	CbGpPWpGaD
Lamivudine—PGK1—Disease—HRAS—pancreatic cancer	6.21e-06	0.000185	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	6.12e-06	0.000182	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.1e-06	0.000182	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	6.02e-06	0.000179	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HSPA1B—pancreatic cancer	5.97e-06	0.000178	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PIK3CB—pancreatic cancer	5.95e-06	0.000177	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—TYMP—pancreatic cancer	5.92e-06	0.000177	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CD44—pancreatic cancer	5.91e-06	0.000176	CbGpPWpGaD
Lamivudine—DCK—Metabolism—APOE—pancreatic cancer	5.9e-06	0.000176	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PTGS2—pancreatic cancer	5.89e-06	0.000176	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GLP1R—pancreatic cancer	5.88e-06	0.000175	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—DPYD—pancreatic cancer	5.79e-06	0.000172	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GCG—pancreatic cancer	5.66e-06	0.000169	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—AKT1—pancreatic cancer	5.64e-06	0.000168	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—AKT1—pancreatic cancer	5.64e-06	0.000168	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—AKT1—pancreatic cancer	5.64e-06	0.000168	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—PIK3CA—pancreatic cancer	5.63e-06	0.000168	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	5.58e-06	0.000166	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	5.53e-06	0.000165	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—SLC2A2—pancreatic cancer	5.49e-06	0.000164	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—PIK3CB—pancreatic cancer	5.49e-06	0.000164	CbGpPWpGaD
Lamivudine—PGK1—Disease—AKT1—pancreatic cancer	5.49e-06	0.000163	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	5.44e-06	0.000162	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CD44—pancreatic cancer	5.43e-06	0.000162	CbGpPWpGaD
Lamivudine—ABCC1—Disease—JAG1—pancreatic cancer	5.35e-06	0.000159	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—STK11—pancreatic cancer	5.32e-06	0.000159	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CG—pancreatic cancer	5.32e-06	0.000159	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.32e-06	0.000158	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	5.3e-06	0.000158	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.27e-06	0.000157	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.25e-06	0.000156	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—PIK3CA—pancreatic cancer	5.23e-06	0.000156	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GCG—pancreatic cancer	5.2e-06	0.000155	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GLP1R—pancreatic cancer	5.18e-06	0.000154	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PTEN—pancreatic cancer	5.14e-06	0.000153	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PPARG—pancreatic cancer	5.14e-06	0.000153	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GLP1R—pancreatic cancer	5.12e-06	0.000153	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—DPYD—pancreatic cancer	5.09e-06	0.000152	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CD44—pancreatic cancer	5.08e-06	0.000151	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HSPA1A—pancreatic cancer	5.04e-06	0.00015	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—DPYD—pancreatic cancer	5.04e-06	0.00015	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—STK11—pancreatic cancer	4.89e-06	0.000146	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—SLC2A2—pancreatic cancer	4.83e-06	0.000144	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—SLC2A2—pancreatic cancer	4.78e-06	0.000143	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PIK3CA—pancreatic cancer	4.78e-06	0.000143	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.78e-06	0.000142	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GLP1R—pancreatic cancer	4.78e-06	0.000142	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	4.72e-06	0.000141	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	4.7e-06	0.00014	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—DPYD—pancreatic cancer	4.7e-06	0.00014	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CD—pancreatic cancer	4.68e-06	0.000139	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—AKT1—pancreatic cancer	4.6e-06	0.000137	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.59e-06	0.000137	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PRSS1—pancreatic cancer	4.58e-06	0.000137	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—TYMS—pancreatic cancer	4.58e-06	0.000136	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SLC2A2—pancreatic cancer	4.46e-06	0.000133	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—HRAS—pancreatic cancer	4.4e-06	0.000131	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—SRC—pancreatic cancer	4.4e-06	0.000131	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	4.36e-06	0.00013	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—VEGFA—pancreatic cancer	4.28e-06	0.000128	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—AKT1—pancreatic cancer	4.27e-06	0.000127	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CD44—pancreatic cancer	4.25e-06	0.000127	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	4.25e-06	0.000127	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—NRAS—pancreatic cancer	4.23e-06	0.000126	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—TYMS—pancreatic cancer	4.21e-06	0.000125	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	4.21e-06	0.000125	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.17e-06	0.000124	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.13e-06	0.000123	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	4.1e-06	0.000122	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CB—pancreatic cancer	4.08e-06	0.000122	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GCG—pancreatic cancer	4.08e-06	0.000121	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PTGS2—pancreatic cancer	4.04e-06	0.00012	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SMAD4—pancreatic cancer	4.01e-06	0.000119	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ARG2—pancreatic cancer	3.97e-06	0.000118	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TGFB1—pancreatic cancer	3.93e-06	0.000117	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HES1—pancreatic cancer	3.92e-06	0.000117	CbGpPWpGaD
Lamivudine—NME2—Metabolism—AKT1—pancreatic cancer	3.91e-06	0.000116	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—STK11—pancreatic cancer	3.83e-06	0.000114	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	3.8e-06	0.000113	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CD44—pancreatic cancer	3.74e-06	0.000112	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—APOE—pancreatic cancer	3.72e-06	0.000111	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CD44—pancreatic cancer	3.7e-06	0.00011	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	3.7e-06	0.00011	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—KRAS—pancreatic cancer	3.64e-06	0.000109	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PIK3CA—pancreatic cancer	3.62e-06	0.000108	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—HRAS—pancreatic cancer	3.62e-06	0.000108	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.6e-06	0.000107	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GCG—pancreatic cancer	3.59e-06	0.000107	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GCG—pancreatic cancer	3.55e-06	0.000106	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PTEN—pancreatic cancer	3.52e-06	0.000105	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—TYMP—pancreatic cancer	3.47e-06	0.000103	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CD44—pancreatic cancer	3.45e-06	0.000103	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TERT—pancreatic cancer	3.43e-06	0.000102	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—APOE—pancreatic cancer	3.42e-06	0.000102	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	3.41e-06	0.000102	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	3.4e-06	0.000101	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—STK11—pancreatic cancer	3.37e-06	0.000101	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—HRAS—pancreatic cancer	3.37e-06	0.0001	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CG—pancreatic cancer	3.36e-06	0.0001	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—PIK3CA—pancreatic cancer	3.35e-06	9.97e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—STK11—pancreatic cancer	3.34e-06	9.95e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	3.33e-06	9.93e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GCG—pancreatic cancer	3.31e-06	9.86e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—TYMS—pancreatic cancer	3.3e-06	9.83e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HIF1A—pancreatic cancer	3.28e-06	9.78e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TSC2—pancreatic cancer	3.27e-06	9.75e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PPARG—pancreatic cancer	3.24e-06	9.66e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.24e-06	9.65e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TP53—pancreatic cancer	3.24e-06	9.65e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—APOE—pancreatic cancer	3.2e-06	9.54e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	3.17e-06	9.46e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	3.15e-06	9.38e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—STK11—pancreatic cancer	3.11e-06	9.27e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—HRAS—pancreatic cancer	3.1e-06	9.22e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CG—pancreatic cancer	3.09e-06	9.2e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PPARG—pancreatic cancer	2.98e-06	8.88e-05	CbGpPWpGaD
Lamivudine—NME1—Metabolism—AKT1—pancreatic cancer	2.96e-06	8.82e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NOTCH1—pancreatic cancer	2.96e-06	8.81e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CD—pancreatic cancer	2.95e-06	8.8e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—TYMS—pancreatic cancer	2.9e-06	8.65e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	2.89e-06	8.62e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—TYMS—pancreatic cancer	2.87e-06	8.56e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EGF—pancreatic cancer	2.86e-06	8.51e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GLP1R—pancreatic cancer	2.8e-06	8.34e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	2.8e-06	8.34e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—DPYD—pancreatic cancer	2.75e-06	8.2e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—AKT1—pancreatic cancer	2.73e-06	8.14e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CD—pancreatic cancer	2.72e-06	8.09e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—APOE—pancreatic cancer	2.68e-06	7.99e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—TYMS—pancreatic cancer	2.68e-06	7.98e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC2A2—pancreatic cancer	2.61e-06	7.78e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CB—pancreatic cancer	2.58e-06	7.67e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTGS2—pancreatic cancer	2.55e-06	7.6e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CD—pancreatic cancer	2.54e-06	7.57e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.54e-06	7.56e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CA—pancreatic cancer	2.49e-06	7.41e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CG—pancreatic cancer	2.42e-06	7.21e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CB—pancreatic cancer	2.37e-06	7.05e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	2.36e-06	7.04e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—APOE—pancreatic cancer	2.36e-06	7.03e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTGS2—pancreatic cancer	2.35e-06	6.99e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PPARG—pancreatic cancer	2.34e-06	6.96e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—APOE—pancreatic cancer	2.34e-06	6.96e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTEN—pancreatic cancer	2.23e-06	6.63e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CB—pancreatic cancer	2.21e-06	6.6e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTGS2—pancreatic cancer	2.19e-06	6.54e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—APOE—pancreatic cancer	2.18e-06	6.49e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CG—pancreatic cancer	2.13e-06	6.35e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CD—pancreatic cancer	2.13e-06	6.34e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CG—pancreatic cancer	2.11e-06	6.28e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PPARG—pancreatic cancer	2.06e-06	6.12e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTEN—pancreatic cancer	2.05e-06	6.09e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PPARG—pancreatic cancer	2.03e-06	6.06e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—AKT1—pancreatic cancer	2.03e-06	6.05e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CD44—pancreatic cancer	2.02e-06	6.03e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CG—pancreatic cancer	1.96e-06	5.85e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CTNNB1—pancreatic cancer	1.96e-06	5.85e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GCG—pancreatic cancer	1.94e-06	5.78e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTEN—pancreatic cancer	1.91e-06	5.7e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PPARG—pancreatic cancer	1.9e-06	5.65e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CD—pancreatic cancer	1.87e-06	5.58e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CB—pancreatic cancer	1.85e-06	5.53e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CD—pancreatic cancer	1.85e-06	5.52e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTGS2—pancreatic cancer	1.84e-06	5.48e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—STK11—pancreatic cancer	1.82e-06	5.43e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SRC—pancreatic cancer	1.77e-06	5.29e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CD—pancreatic cancer	1.73e-06	5.15e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—STAT3—pancreatic cancer	1.71e-06	5.1e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NRAS—pancreatic cancer	1.71e-06	5.09e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CB—pancreatic cancer	1.63e-06	4.86e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTGS2—pancreatic cancer	1.62e-06	4.82e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CB—pancreatic cancer	1.62e-06	4.81e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTEN—pancreatic cancer	1.6e-06	4.78e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTGS2—pancreatic cancer	1.6e-06	4.77e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MYC—pancreatic cancer	1.59e-06	4.74e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TGFB1—pancreatic cancer	1.59e-06	4.73e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CA—pancreatic cancer	1.57e-06	4.68e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—TYMS—pancreatic cancer	1.57e-06	4.67e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EGFR—pancreatic cancer	1.56e-06	4.63e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CB—pancreatic cancer	1.51e-06	4.49e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTGS2—pancreatic cancer	1.49e-06	4.44e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—KRAS—pancreatic cancer	1.47e-06	4.38e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CA—pancreatic cancer	1.44e-06	4.3e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTEN—pancreatic cancer	1.41e-06	4.2e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTEN—pancreatic cancer	1.4e-06	4.16e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CA—pancreatic cancer	1.35e-06	4.02e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTEN—pancreatic cancer	1.3e-06	3.88e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AKT1—pancreatic cancer	1.28e-06	3.82e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—APOE—pancreatic cancer	1.28e-06	3.8e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HRAS—pancreatic cancer	1.25e-06	3.72e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AKT1—pancreatic cancer	1.18e-06	3.51e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CG—pancreatic cancer	1.15e-06	3.43e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CA—pancreatic cancer	1.13e-06	3.37e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PPARG—pancreatic cancer	1.11e-06	3.31e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKT1—pancreatic cancer	1.1e-06	3.29e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	1.01e-06	3.02e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CA—pancreatic cancer	9.95e-07	2.96e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CA—pancreatic cancer	9.85e-07	2.93e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AKT1—pancreatic cancer	9.24e-07	2.75e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CA—pancreatic cancer	9.18e-07	2.73e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	8.82e-07	2.63e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTGS2—pancreatic cancer	8.74e-07	2.61e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AKT1—pancreatic cancer	8.13e-07	2.42e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AKT1—pancreatic cancer	8.04e-07	2.4e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTEN—pancreatic cancer	7.63e-07	2.27e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AKT1—pancreatic cancer	7.5e-07	2.23e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	5.38e-07	1.6e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AKT1—pancreatic cancer	4.39e-07	1.31e-05	CbGpPWpGaD
